UHRF1 is a genome caretaker that facilitates the DNA damage response to γ-irradiation

Genome Integrity

Volumn 1, Issue , 2010, Pages

  Mistry, Helena ^a   Tamblyn, Laura ^a   Butt, Hussein ^a   Sisgoreo, Daniel ^a   Gracias, Aileen ^a   Larin, Meghan ^a   Gopalakrishnan, Kalpana ^b   Hande, Manoor P ^b   McPherson, John P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; GAMMA HISTONE H2AX; HISTONE H2AX; SHORT HAIRPIN RNA; UBIQUITIN PROTEIN LIGASE E3; UHRF1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CHROMOSOME ABERRATION; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; FACILITATION; GAMMA IRRADIATION; GENE FREQUENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY;

EID: 78650967451     PISSN: None     EISSN: 20419414     Source Type: Journal    
DOI: 10.1186/2041-9414-1-7     Document Type: Article

References (43)

1. Muto M, Utsuyama M, Horiguchi T, Kubo E, Sado T, Hirokawa K. The characterization of the monoclonal antibody Th-10a, specific for a nuclear protein appearing in the S phase of the cell cycle in normal thymocytes and its upregulated expression in lymphoma cell lines. Cell Proliferation 1995, 28:645-657. 10.1111/j.1365-2184.1995.tb00051.x, 8634372.
2. Fujimori A, Matsuda Y, Takemoto Y, Hashimoto Y, Kubo E, Araki R, Fukumura R, Mita K, Tatsumi K, Muto M. Cloning and mapping of NP95 gene which encodes a novel nuclear protein associated with cellular proliferation. Mamm Genome 1998, 9:1032-1035. 10.1007/s003359900920, 9880673.
3. Uemura T, Kubo E, Kanaari Y, Ikemura T, Tatsumi K, Muto M. Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. Cell Structure and Function 2000, 25:149-159. 10.1247/csf.25.149, 10984098.
4. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H. Down-regulation of nuclear protein ICBP90 by p53/p21-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells 2004, 9:131-142. 10.1111/j.1356-9597.2004.00710.x, 15009091.
5. Bonapace IM, Latella L, Papait R, Nicassio F, Sacco A, Muto M, Crescenzi M, Di Fiore PP. Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry. J Cell Biol 2002, 157:909-914. 10.1083/jcb.200201025, 2174046, 12058012.
6. Papait R, Pistore C, Negri D, Pecoraro D, Cantarini L, Bonapace IM. Np95 is implicated in pericentromeric Heterochromatin replication and in major satellite silencing. Mol Biol Cell 2007, 18:1098-1106. 10.1091/mbc.E06-09-0874, 1805105, 17182844.
7. Karagianni P, Amazit L, Qin J, Wong J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol 2008, 28:705-717. 10.1128/MCB.01598-07, 2223417, 17967883.
8. Citterio E, Papait R, Nicassio F, Vecchi M, Gomiero P, Mantovani R, Di Fiore PP, Bonapace IM. Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol Cell Biol 2004, 24:2526-2535. 10.1128/MCB.24.6.2526-2535.2004, 355858, 14993289.
9. Unoki M, Nishidate T, Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 2004, 23:7601-7610. 10.1038/sj.onc.1208053, 15361834.
10. Bostick M, Kim JK, Esteve P-O, Clark A, Pradham S, Jacobsen SE. UHFR1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764. 10.1126/science.1147939, 17673620.
11. Sharif J, Muto M, Takebayashi S-I, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T, Okamura K, Tajima S, Mitsuya K, Okano M, Koseki H. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912. 10.1038/nature06397, 17994007.
12. Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821. 10.1038/nature07249, 18772891.
13. Avvakumov GV, Walker JR, Xue S, Li Y, Duan S, Bronner C, Arrowsmith CH, Dhe-Paganon S. Structural basis for recognition of hemi-methylated DNA by the SRA domains of human UHRF1. Nature 2008, 455:822-825. 10.1038/nature07273, 18772889.
14. Qian C, Li S, Jakonic J, Zeng L, Walsh MJ, Zhou MM. Structure and hemi-methylated CpG binding of the SRA domain from human UHRF1. J Biol Chem 2008, 283:34490-34494. 10.1074/jbc.C800169200, 2596396, 18945682.
15. Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H. The multi-domain protein Np95 connects DNA methylation and histone modification. Nucl Acids Res 2010, 38(6):1796-804. 10.1093/nar/gkp1152, 2847221, 20026581.
16. Achour M, Jacq X, Ronde P, Alhosin M, Charlot C, Jeanblanc M, Macaluso M, Giordano A, Hughes AD, Schini-Kerth VB, Bronner C. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 2008, 27:2187-2197. 10.1038/sj.onc.1210855, 17934516.
17. Kim JK, Esteve PO, Jacobsen SE, Pradham S. Uhrf1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucl Acids Res 2008, 37:493-505. 10.1093/nar/gkn961, 2632929, 19056828.
18. Meilenger D, Fellinger K, Bultmann S, Rothbauer U, Bonapace IM, Klinkert WEF, Spada F, Leonhardt H. Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells. EMBO reports 2009, 10:1259-1264. 10.1038/embor.2009.201, 2756565, 19798101.
19. Jin W, Liu Y, Xu S, Win W, Li J, Yang J, Shao ZM. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. Breast Cancer Res Treat 2009, DOI: 10.1007/s10549-009-0683-8..
20. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A, Tatsumi K. Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J Biol Chem 2002, 277:34549-34555. 10.1074/jbc.M205189200, 12084726.
21. Muto M, Fujimori A, Nenoi M, Daino K, Matsuda Y, Kuroiwa A, Kubo E, Kanari Y, Utsuno M, Tsuji H, Ukai H, Mita K, Takahagi M, Tatsumi K. Isolation and characterization of a novel human radiosusceptibility gene, NP95. Radiation Research 2006, 723-733. 10.1667/RR0459.1, 17067204.
22. Tamblyn L, Li E, Sarras H, Srikanth P, Hande MP, McPherson JP. A role for Mus81 in the repair of chromium-induced DNA damage. Mutation Research 2009, 660:57-65.
23. Hande MP, Samper E, Landsdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase-null mice. J Cell Biol 1999, 144:589-601. 10.1083/jcb.144.4.589, 2132934, 10037783.
24. Papait R, Pistore C, Grazini U, Babbio F, Cogliati S, Pecoraro D, Brino L, Morand AL, Dechampesme AM, Spada F, Leonhardt H, McBlane F, Oudet P, Bonapace IM. The PHD domain of Np95 (mUHRF1) is involved in large-scale reorganization of pericentromeric heterochromatin. Molecular Biology of the Cell 2008, 19:3554-3563. 10.1091/mbc.E07-10-1059, 2488286, 18508923.
25. Jenkins Y, Markovtsov V, Lang W, Sharma P, Pearsall D, Warner J, Franci C, Huang B, Huang J, Yam GC, Vistan JP, Pali E, Vialard J, Janicot M, Lorens JB, Payan DG, Hitoshi Y. Critical role of the ubiquitin ligase activity of UHFR1, a nuclear RING finger protein, in tumour cell growth. Mol Biol Cell 2005, 16:5621-5629. 10.1091/mbc.E05-03-0194, 1289407, 16195352.
26. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology 2000, 10:886-895. 10.1016/S0960-9822(00)00610-2, 10959836.
27. Therman E, Susman M. Human Chromosomes, Structure, Behaviour and Effects. 1993, New York, NY: Springer-Verlag.
28. Hoffelder DR, Luo L, Burke NA, Watkins SC, Gollin SM, Saunders WS. Resolution of anaphase bridges in cancer cells. Chromosoma 2004, 112:389-397. 10.1007/s00412-004-0284-6, 15156327.
29. Taddei A, Maison C, Roche D, Almouzni G. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nature Cell Biol 2001, 3:114-120. 10.1038/35055010, 11175742.
30. Peters AHFM, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. Loss of the Suv39 h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107:323-337. 10.1016/S0092-8674(01)00542-6, 11701123.
31. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007, 28:739-745. 10.1016/j.molcel.2007.11.015, 18082599.
32. Dery U, Masson JY. Twists and turns in the function of DNA damage signaling and repair proteins by post-translational modifications. DNA Repair 2007, 6:561-577. 10.1016/j.dnarep.2006.12.009, 17258515.
33. Murga M, Jaco I, Fan Y, Soria R, Martinez-Pastor B, Cuadrado M, Yang SM, Blasco MA, Skoultchi AI, Fernandez-Capetillo O. Global chromatin compaction limits the strength of the DNA damage response. J Cell Biol 2007, 178:1101-1108. 10.1083/jcb.200704140, 2064646, 17893239.
34. Karagiannis TC, KN H, El-Osta A. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. Oncogene 2007, 26:3963-3971. 10.1038/sj.onc.1210174, 17213813.
35. Cowell IG, Sunter NJ, Singh PB, Austin CA, Durkacz BW, Tilby MJ. Gamma H2AX foci form preferentially in euchromatin after ionizing radiation. PLoS ONE 2007, 2:e1057. 10.1371/journal.pone.0001057, 2020439, 17957241.
36. Ayoub N, Jeyasekharan AD, Bernal JA, Venkitaraman AR. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 2008, 453:682-686. 10.1038/nature06875, 18438399.
37. Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M, Jeggo PA. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 2008, 31:167-177. 10.1016/j.molcel.2008.05.017, 18657500.
38. Luijsterburg MS, Dinant C, Lans H, Stap J, Wiernasz E, Lagerwerf S, Warmerdam DO, Lindh M, Brink MC, Dobrucki JW, Aten JA, Fousteri MI, Jansen G, Dantuma NP, Vermeulen W, Mullenders LHF, Houtsmuller AB, Verschure PJ, van Driel R. Heterochromatin protein 1 is recruited to various types of DNA damage. J Cell Biol 2009, 185:577-586. 10.1083/jcb.200810035, 2711568, 19451271.
39. Aucott R, Bullwinkel J, Yu Y, Shi W, Billur M, Brown JP, Menzel U, Kioussis D, Wang G, Reisert I, Weimer J, Pandita RK, Sharma GG, Pandita TK, Fundele R, Singh PB. HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions. J Cell Biol 2008, 183:597-606. 10.1083/jcb.200804041, 2582898, 19015315.
40. Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC, Lukas J, Bekker-Jensen S, Bartek J, Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nature Cell Biol 2006, 8:870-876. 10.1038/ncb1446, 16862143.
41. Sun Y, Jiang X, Xu Y, Ayrapetov MK, Moreau LA, Whetstine JR, Price BD. Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nature Cell Biol 2009, 11:1376-1382. 10.1038/ncb1982, 2783526, 19783983.
42. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007, 128:669-681. 10.1016/j.cell.2007.01.033, 17320505.
43. Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S, Wang Q, Chia D, Goodglick L, Kurdistani SK. Global levels of histone modifications predict prognosis in different cancers. American Journal of Pathology 2009, 174:1619-1628. 10.2353/ajpath.2009.080874, 2671251, 19349354.